Global In-Vitro Colorectal Cancer Screening Tests Market, By Product (Fecal Occult Blood Test, Biomaker Tests and CRC DNA Screening Tests), End-User (Hospitals, Clinics, Diagnostics laboratories and Ambulatory Surgical Centers), Application (MarCarePlex, Cologic, Colox, miRDIGN, PanC?Dx and MeSorce CRC), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
In-vitro colorectal cancer screening tests market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to reach at USD 1316.7 million and at a growth rate CAGR of 6.40% in the above-mentioned forecast period. Introduction of novel screening tests employing genetic testing, growing incidence of rectal and colon cancer are some factors driving the growth of the market.
Colorectal cancer can be of two types that is bowel cancer and colon cancer, or any cancer which affect the rectum or colon. Most colorectal cancer starts with a growth on the inner lining of colon or rectum, as they are known as polyps and these polyps sometimes change into cancer. In-vitro colorectal cancer screening tests are performed to check the presence of colorectal cancer.
Growing demand for novel minimally invasive tests which screens colorectal cancer using genetic biomarker and DNA, government regulations aimed at mandatory applications of cancer screening tests and increased prevalence of colorectal cancer are driving the growth of the market. Technological advancements which include high speed DNA sequencing and with cost effectiveness of DNA sequencing will drive the growth of the market. Growing R&D for developing advanced DNA sequencing methods such as hybridization, RNAP sequencing, microfluidic sequencing will further create new opportunities for in-vitro colorectal cancer screening tests market the is segmented into in the forecast period of 2020- 2027.
Lack of trained professionals in developing countries, lack of uniform cancer screening guidelines will act as a restrain, and further challenge the growth of the in-vitro colorectal cancer screening tests market in the forecast period mentioned above.
This In-vitro colorectal cancer screening tests market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info in-vitro colorectal cancer screening tests market on Data Bridge Market Research contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global In-Vitro Colorectal Cancer Screening Tests Market Scope and Market Size
In-vitro colorectal cancer screening tests market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the in-vitro colorectal cancer screening tests market is segmented into fecal occult blood test, biomarker tests, CRC DNA screening tests. Fecal occult test is further segmented into guaiac FOB stool tests, immune FOB agglutination test, lateral flow immune FOB test and immune FOB ELISA test. Biomaker tests are further segmented into tumor M2-PK Stool test and Transferrin Assays. CRC DNA screening test is further segmented into methylated gene testing and panel DNA tests.
- On the basis of end-user, the in-vitro colorectal cancer screening tests market is segmented into hospitals, clinics, diagnostics laboratories and ambulatory surgical centers.
- Based on application, the in-vitro colorectal cancer screening tests market is segmented into MarCarePlex, Cologic, Colox, miRDIGN, PanC?Dx and MeSorce CRC.
Global In-Vitro Colorectal Cancer Screening Tests Market Country Level Analysis
In-vitro colorectal cancer screening tests market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the In-vitro colorectal cancer screening tests market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market as the U.S is most lucrative country for in-vitro colorectal cancer screening tests market due to higher prevalence rate and improved healthcare infrastructure.
The country section of the in-vitro colorectal cancer screening tests market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
In-vitro colorectal cancer screening tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products in-vitro colorectal cancer screening tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the in-vitro colorectal cancer screening tests market. The data is available for historic period 2010 to 2018.
Competitive Landscape In-Vitro Colorectal Cancer Screening Tests Market and Share Analysis
In-vitro colorectal cancer screening tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to in-vitro colorectal cancer screening tests market.
The major players covered in the in-vitro colorectal cancer screening tests market report are Abbott, Clinical Genomics Technologies Pty, Ltd, Epigenomics Inc, Hemosure, Inc, Exact Sciences Corporation, NOVIGENIX SA, Sekisui Diagnostics, Medline Industries, Inc, Beckman Coulter, Inc, Eiken Chemical Co, Ltd, Sysmex Corporation, Siemens Healthcare Private Limited, Quest Diagnostics Incorporated, Oncocyte, Merck KGaA, Immunostics Inc, ExiQon, Kyowa Electronic Instruments Co. Ltd, R-Biopharm AG among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global In-Vitro Colorectal Cancer Screening Tests Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.